Fiscal Year:
1989
Title:
RADIOLABELED ANTIBODY DELIVERY SYSTEM QUALITY CONTROL
Agency:
HHS
Contract:
N/A
Award Amount:
$482,000.00
Abstract:
A QUALITY CONTROL (QC) TEST KIT WILL BE DEVELOPED AND AND VALIDATED FOR USE IN MEASURING THE PERCENTAGE OF IMMUNOREACTIVE RADIOACTIVITY OF RADIOLABELED ANTIBODY OR ANTIBODY FRAGMENTS INTENDED FOR PATIENT USE. THIS QC PRODUCT IS BEING DESIGNED FOR A MULTICENTERED CLINICAL TRIALOF COMPOUNDED, RADIOLABELED ANTIBODIES. PANELS OF CURRENTLYAVAILABLE MONOCLONAL ANTIBODIES (MABS) THAT HAVE POTENTIAL FOR TARGETING DRUGS AND RADIOISOTOPES TO TUMORS WILL BE SELECTED FOR INCLUSION IN THE CLINICAL TRIAL. THIS PRODUCT WILL BE USED IN AN ANTIBODY DELIVERY SYSTEM, WHICH WILL EMPLOY A MONOCLONAL ANTIBODY/TUMOR-ASSOCIATED ANTIGEN (MAB/TAA) MATCHING KIT TO SELECT ANTIBODIES FOR USE IN INDIVIDUAL PATIENTS. THE QC TEST RESULTS WILL BE USED TO DETERMINE ACCEPTABILITY OF THE COMPOUNDED DRUG FOR PATIENT USE AND FOR POOLING OF DATA FROM DIFFERENT INSTITUTIONS.
Principal Investigator:
Buck A Rhodes
Principal Investigator
5052560595
Business Contact:
Small Business Information at Submission:
Rhomed Inc.
1104 Stanford Drive Northeast Albuquerque, NM 87106
EIN/Tax ID:
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned:
No
Minority-Owned:
No
HUBZone-Owned:
No